Atlas Trials

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Clinical trial NCT01466088 · COMPLETED

Trial details

NCT number
NCT01466088
Sponsor
Targacept Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2011-10-01
Primary completion
2014-05-01
Enrollment
386

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.